Postmortem genetic screening for the identification, verification, and reporting of genetic variants contributing to the sudden death of the young

Genome Research

Volumn 26, Issue 9, 2016, Pages 1170-1177

  Methner, D Nicole R ^a   Scherer, Steven E ^b   Welch, Katherine ^a   Walkiewicz, Magdalena ^c   Eng, Christine M ^c   Belmont, John W ^b,c   Powell, Mark C ^a   Korchina, Viktoriya ^b   Doddapaneni, Harsha Vardhan ^b   Muzny, Donna M ^b   Gibbs, Richard A ^b   Wolf, Dwayne A ^a   Sanchez, Luis A ^a   Kahn, Roger ^a  

^a Harris County Institute of Forensic Sciences   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Department of Molecular and Human Genetics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL NAV1.5; VOLTAGE GATED SODIUM CHANNEL BETA 3 SUBUNIT;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EXON; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; INFANT; MALE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME; YOUNG ADULT; CARDIOMYOPATHY; EPIDEMIOLOGY; ETIOLOGY; GENETIC VARIATION; GENETICS; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AUTOPSY; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; DIAGNOSIS; FEMALE; GENETIC TESTING; GENETIC VARIATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; UNITED STATES; YOUNG ADULT;

EID: 84984950121     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.195800.115     Document Type: Article

References (46)

1. Ackerman MJ. 2005. Cardiac causes of sudden unexpected death in children and their relationship to seizures and syncope: genetic testing for cardiac electropathies. Semin Pediatr Neurol 12: 52-58.
2. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, Keating MT, Jones G, Chadha M, Burrow CR, et al. 2004. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1: 600-607.
3. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, et al. 2011. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13: 1077-1109.
4. Adey A, Morrison HG, Asan, Xun X, Kitzman JO, Turner EH, Stackhouse B, MacKenzie AP, Caruccio NC, Zhang X, et al. 2010. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol 11: R119.
5. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
6. Bai R, Napolitano C, Bloise R, Monteforte N, Priori SG. 2009. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol 2: 6-15.
7. Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, Thiene G, van der Wal A, Association for European Cardiovascular Pathology. 2010. Guidelines for autopsy investigation of sudden cardiac death. Pathologica 102: 391-404.
8. Brion M, Blanco-Verea A, Sobrino B, Santori M, Gil R, Ramos-Luis E, Martinez M, Amigo J, Carracedo A. 2014. Next generation sequencing challenges in the analysis of cardiac sudden death due to arrhythmogenic disorders. Electrophoresis 35: 21-22.
9. Challis D, Yu J, Evani US, Jackson AR, Paithankar S, Coarfa C, Milosavljevic A, Gibbs RA, Yu F. 2012. An integrative variant analysis suite for whole exome next-generation sequencing data. BMC Bioinformatics 13: 8.
10. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. 2012. Predicting the functional effect of amino acid substitutions and indels. PLoS One 7: E46688.
11. Clarke AJ. 2014. Managing the ethical challenges of next-generation sequencing in genomic medicine. Brit Med Bull 111: 17-30.
12. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al. 2011. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
13. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, Bennett RL, Jones KL, Tokita MJ, Bennett JT, et al. 2013. Actionable, pathogenic incidental findings in 1, 000 participants' exomes. Am J Hum Genet 93: 631-640.
14. Giudici V, Spanaki A, Hendry J, Mead-Regan S, Field E, Zuccotti GV, Abrams D, Lowe M, Kaski JP. 2014. Sudden arrhythmic death syndrome: diagnostic yield of comprehensive clinical evaluation of pediatric first-degree relatives. Pacing Clin Electrophysiol 37: 1681-1685.
15. Jind L, Elklit A, Christiansen D. 2010. Cognitive schemata and processing among parents bereaved by infant death. J Clin Psychol Med Settings 17: 366-377.
16. Klaver EC, Versluijs GM, Wilders R. 2011. Cardiac ion channel mutations in the sudden infant death syndrome. Int J Cardiol 152: 162-170.
17. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR. 2014. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42: D980-D985.
18. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 25: 1754-1760.
19. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R; 1000 Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
20. Liberthson RR. 1996. Sudden death from cardiac causes in children and young adults. N Engl J Med 334: 1039-1044.
21. Loporcaro CG, Tester DJ, Maleszewski JJ, Kruisselbrink T, Ackerman MJ. 2014. Confirmation of cause and manner of death via a comprehensive cardiac autopsy including whole exome next-generation sequencing. Arch Pathol Lab Med 138: 1083-1089.
22. Matthews TJ, MacDorman MF. 2013. Infant mortality statistics from the 2010 period linked birth/infant death data set. In Vital health statistics, Vol. 62, pp. 1-26. National Center for Health Statistics, Hyattsville, MD.
23. McGuire AL, Moore Q, Majumder M, Walkiewicz M, Eng CM, Belmont JW, Nassef S, Darilek S, Rutherford K, Pereira S, et al. 2016. The ethics of conducting molecular autopsies in cases of sudden death in the young. Genome Res (this issue) 26: 1165-1169.
24. McVean GA, Donnelly P, Lunter G, Marchini J, Myers S, Gupta-Hinch A, Iqbal Z. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491: 56-65.
25. Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11: 863-874.
26. Papadakis M, Raju H, Behr ER, De Noronha SV, Spath N, Kouloubinis A, Sheppard MN, Sharma S. 2013. Sudden cardiac death with autopsy findings of uncertain significance: potential for erroneous interpretation. Circ Arrhythm Electrophysiol 6: 588-596.
27. Reid JG, Carroll A, Veeraraghavan N, Dahdouli M, Sundquist A, English A, Bainbridge M, White S, Salerno W, Buhay C, et al. 2014. Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline. BMC Bioinformatics 15: 30.
28. Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. 2008. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 10: 294-300.
29. Ross LF, Saal HM, David KL, Anderson RR; American Academy of Pediatrics; American College of Medical Genetics and Genomics. 2013. Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med 15: 234-245.
30. Shen WK, Edwards WD, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ. 1995. Sudden unexpected nontraumatic death in 54 young adults: A 30-year population-based study. Am J Cardiol 76: 148-152.
31. Shephard R, Semsarian C. 2009. Advances in the prevention of sudden cardiac death in the young. Ther Adv Cardiovasc Dis 3: 145-155.
32. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. 2001. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
33. Shim SH, Ito M, Maher T, Milunsky A. 2005. Gene sequencing in neonates and infants with the long QT syndrome. Genetic Test 9: 281-284.
34. Skinner JR, Duflou JA, Semsarian C. 2008. Reducing sudden death in young people in Australia and New Zealand: The TRAGADY initiative. Med J Aust 189: 539-540.
35. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. 2014. The Human Gene Mutation Database: Building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133: 1-9.
36. Tang Y, Stahl-Herz J, Sampson BA. 2014. Molecular diagnostics of cardiovascular diseases in sudden unexplained death. Cardiovasc Pathol 23: 1-4.
37. Tester DJ, Ackerman MJ. 2006. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 21: 166-172.
38. Tester DJ, Ackerman MJ. 2009. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Annu Rev Med 60: 69-84.
39. Tester DJ, Will ML, Haglund CM, Ackerman MJ. 2005. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2: 507-517.
40. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ. 2012. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc 87: 524-539.
41. Trachtenberg FL, Haas EA, Kinney HC, Stanley C, Krous HF. 2012. Risk factor changes for sudden infant death syndrome after initiation of Backto- Sleep campaign. Pediatrics 129: 630-638.
42. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy- Moonshine A, Jordan T, Shakir K, Roazen D, Thibault J, et al. 2013. From FastQ data to high confidence variant calls: The Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 43: 111011-111033.
43. Van Driest SL, Wells QS, Stallings S, Bush WS, Gordon A, Nickerson DA, Kim JH, Crosslin DR, Jarvik GP, Carrell DS, et al. 2016. Association of arrhythmia- related genetic variants with phenotypes documented in electronic medical records. JAMA 315: 47-57.
44. Van Norstrand DW, Ackerman MJ. 2010. Genomic risk factors in sudden infant death syndrome. Genome Med 2: 86.
45. Wang D, Shah KR, UmSY, Eng LS, Zhou B, Lin Y, Mitchell AA, Nicaj L, Prinz M, McDonald TV, et al. 2014. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. Forensic Sci Int 237: 90-99.
46. Wong LC, Behr ER. 2014. Sudden unexplained death in infants and children: The role of undiagnosed inherited cardiac conditions. Europace 16: 1706-1713.